- Home
- HHH vs VCYT Comparison
HHH vs VCYT Comparison
Compare HHH & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HHH | VCYT |
|---|---|---|
| Founded | 2010 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical Specialities |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 3.1B |
| IPO Year | 2023 | 2013 |
Fundamental Metrics
Financial Performance| Metric | HHH | VCYT |
|---|---|---|
| Price | $67.93 | $41.79 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 7 |
| Target Price | ★ $90.00 | $44.00 |
| AVG Volume (30 Days) | 395.1K | ★ 1.3M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 164.52 |
| EPS | ★ 2.82 | 0.66 |
| Revenue | ★ $1,474,892,000.00 | N/A |
| Revenue This Year | $14.04 | $13.76 |
| Revenue Next Year | N/A | $12.35 |
| P/E Ratio | ★ $24.18 | $63.92 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $61.01 | $28.25 |
| 52 Week High | $91.07 | $60.91 |
Technical Indicators
Market Signals| Indicator | HHH | VCYT |
|---|---|---|
| Relative Strength Index (RSI) | 53.38 | 34.56 |
| Support Level | $62.04 | $41.03 |
| Resistance Level | $68.95 | $42.98 |
| Average True Range (ATR) | 1.61 | 2.02 |
| MACD | 0.27 | -0.53 |
| Stochastic Oscillator | 73.84 | 23.59 |
Price Performance
Historical ComparisonAbout HHH Howard Hughes Holdings Inc.
Howard Hughes Holdings Inc, through its subsidiary, operates a large-scale, mixed-use real estate platform focused on the development of master planned communities (MPCs), the investment in strategic real estate development opportunities, and the ownership and operation of income-producing properties. The group operates through three reportable business segments: Operating Assets, MPCs, and Strategic Developments. Maximum revenue is generated from the MPC segment, which consists of the development and sale of land in large-scale, long-term community development projects in and around Las Vegas, Nevada; Houston, Texas; and Phoenix, Arizona. Revenues are mainly generated through the sale of residential and commercial land to homebuilders and developers.
About VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).